Ketamine used in patients with treatment-resistant depression operates via serotonin 1B receptors by way of a previously unknown mechanism of action, according to a new study from Sweden.
Analysis of EEG data from patients with major depressive disorder predicted response to SSRI treatment with accuracy of nearly 80%, according to a new study.
Highlights from a recent evidence-based review offer guidance on feasible depression treatments in primary care.
Highlights of an evidence-based review offer practical guidance for effective depression screening and assessment strategies for primary care physicians.
A new study being presented next week at AHA's 2019 Scientific Sessions found a strong link between depression and non-fatal heart disease.
A new study suggests that deep brain stimulation may be a safe and effective treatment option for patients with treatment-resistant depression.
Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus,® and 8 more new and approved drugs.
This month, our app reviewer selected the top 5 depression apps that you and your patients can use. Which ones made the cut?
Five tips for PCPs on managing treatment-resistant depression were offered at the ACP Internal Medicine Meeting 2018 today. Patient Care offers a summary.